Detalhe da pesquisa
1.
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.
J Infect Dis
; 227(10): 1203-1213, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408618
2.
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
N Engl J Med
; 381(20): 1897-1908, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722150
3.
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
J Infect Dis
; 223(6): 1062-1072, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726422
4.
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
Vaccine
; 39(22): 3067-3080, 2021 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077299
5.
Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry.
Immunity
; 22(4): 451-65, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15845450